BeiGene has announced that its Tevimbra (tislelizumab) has been approved by the European Commission (EC) as part of a ...

Private equity firm Apiary Capital has completed its investment into life sciences performance marketing and specialist ...

Gene therapy has the potential to change lives, slowing or stopping disease progression or even correcting symptoms entirely, ...

What impact can we expect from the abolition of NHS England (NHSE) and changes at the Department of Health and Social Care ...

The answer is yes, pharma can have an impact We can and should use our expertise and resources to tackle misinformation.

The US Food and Drug Administration (FDA) has announced that all its centres will operate on a common generative artificial ...

AstraZeneca (AZ) and Daiichi Sankyo have shared positive results from a late-stage study of their HER2-directed antibody drug ...

Tiziana Life Sciences has announced promising results from an open-label study of its investigational multiple sclerosis (MS) ...

AstraZeneca (AZ) has announced that its Bruton’s tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) has been approved ...

Eli Lilly will be licensing Alchemab Therapeutics’ preclinical programme for amyotrophic lateral sclerosis (ALS) and other ...

The network has introduced a new agency and aligned its medical communications, medical affairs and publications capabilities ...

Connected patches can be used to monitor vital patient parameters in real time, including heart rate, oxygen saturation, ...